MedTrace Logo

A Study of NCR100 Injection for the Treatment of Knee Osteoarthritis（ KOA）

NCT06741098 · Status: NOT_YET_RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 162

Last updated 2024-12-18

No results posted yet for this study

Summary

This clinical study is to investigate the safety and efficacy of NCR100 injection in subjects with knee osteoarthritis (KOA). It contains two parts dose-escalating, and blind random study in adult KOA subjects.

Conditions

Interventions

BIOLOGICAL

NCR100

Subjects will receive multiple intra-articular NCR100 injections.

OTHER

0.9% Normal saline

Subjects will receive multiple intra-articular 0.9% Normal saline injections.

Sponsors & Collaborators

  • Shanghai 6th People's Hospital

    collaborator OTHER

  • Nuwacell Biotechnologies Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-20
Primary Completion
2026-11-30
Completion
2028-11-15

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06741098 on ClinicalTrials.gov